Nutlin-3 sensitizes nasopharyngeal carcinoma cells to cisplatin-induced cytotoxicity
The small-molecule inhibitor of p53-Mdm2 interaction, Nutlin-3, is known to be effective against cancers expressing wild-type (wt) p53. p53 mutations are rare in nasopharyngeal carcinoma (NPC), hence targeting disruption of p53-Mdm2 interaction to reactivate p53 may offer a promising therapeutic str...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Published: |
Spandidos Publications
2015
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/19489/ http://dx.doi.org/10.3892/or.2015.4177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|